You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

Research servicesContraceptive technology innovationResearch

8 Results Found

  • Published research

    Behavioral effects of different contraceptive methods and HIV acquisition: An ancillary study of the ECHO randomized trial

  • Project

    LNG Long-Acting Microsphere Injectable Contraceptive

    Funded by the Bill & Melinda Gates Foundation, FHI 360 is developing a six-month levonorgestrel self-injectable contraceptive: the LNG long-acting microsphere injectable, or the LLMI.
  • Project

    Development of a Biodegradable Implant for Contraception

    Funded by the Bill & Melinda Gates Foundation, FHI 360 is conducting preclinical work and a first-in- human study on a biodegradable contraceptive implant called Casea S.
  • Project

    Innovate FP: Expanding Options, Enhancing Method Choice

    Innovate FP is a contraceptive research project to expand desirable, affordable, quality contraceptive options to better meet the needs of women.
  • Event

    International Conference on Family Planning: #NextGenFP and FHI 360

    At the 2018 International Conference on Family Planning, FHI 360 shares results from our latest research, programs, innovative interventions and digital technologies.
  • Published research

    Opportunity, satisfaction and regret: Trying long acting reversible contraception in a unique scientific circumstance

    The authors interviewed women ages 20 to 30 years and found that cost and uncertainty about whether long-acting reversible contraception (LARC) is the right method for them may deter them from trying LARC. Participants more frequently reported regret from discontinuing LARC than regret from trying it. The authors suggest that LARC should be made affordable, and providers should offer it and provide counseling to continue use.
  • Feature

    Removing cost and access barriers to contraceptive implants (audio)

    Markus Steiner and Kate Rademacher of FHI 360 discuss the long-term effort to increase global access to contraceptive implants at an affordable price.
  • Published research

    Prevalence and risk factors associated with STIs among women initiating contraceptive implants in Kingston, Jamaica

    This paper examines the prevalence of sexually transmitted infections (STIs) as a part of the Sino-implant (II) study, a trial in Kingston, Jamaica, that evaluated whether the initiation of the implant led to more unprotected sex among women ages 18 to 44 years. The authors found that the immediate initiation of Sino-implant (II) was not associated with higher STI prevalence rates over three months for these women. These findings fill an important gap in the evidence regarding the effect of initiation of long-acting reversible contraceptives on STIs.